Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography

BACKGROUND: Antiangiogenesis is a promising therapy for advanced hepatocellular carcinoma (HCC), but the effects are difficult to be evaluated. Pazopanib (GW786034B) is a pan-vascular endothelial growth factor receptor inhibitor, the antitumor effects or antiangiogenic effects haven't been inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiao-Dong, Zhang, Ju-Bo, Fan, Pei-Li, Xiong, Yu-Quan, Zhuang, Peng-Yuan, Zhang, Wei, Xu, Hua-Xiang, Gao, Dong-Mei, Kong, Ling-Qun, Wang, Lu, Wu, Wei-Zhong, Tang, Zhao-You, Ding, Hong, Sun, Hui-Chuan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033852/
https://www.ncbi.nlm.nih.gov/pubmed/21251271
http://dx.doi.org/10.1186/1471-2407-11-28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033852/
https://www.ncbi.nlm.nih.gov/pubmed/21251271
http://dx.doi.org/10.1186/1471-2407-11-28

Ejemplares similares